1.	Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: Protocol IDs: EORTC-08881
2.	Phase I/II Regional Chemotherapy with CACP/DCM for Advanced Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UAB-154, NCI-T83-1229D, T83-1229
3.	Phase I/II Comparative Evaluation of Continuous vs Intermittent CACP in Solid Tumors Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MDA-DM-8490, NCI-V85-0135
4.	Phase I/II Study of Escalating Single Doses of Metoclopramide Given in Combination with Dexamethasone and Lorazepam for the Control of Cisplatin-Induced Nausea and Vomiting (Summary Last Modified 02/91) Phase: Phase II, Phase I Type: Supportive care Status: Completed Age: 30 and over Sponsor: Protocol IDs: MSKCC-88074, NCI-V88-0580
5.	Phase II Randomized Study of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients With Newly Diagnosed Cancer Phase: Phase II Type: Supportive care Status: Completed Age: 8 to 18 Sponsor: NCI Protocol IDs: SCUSF-0503, HLMCC-0503, SCUSF-0503, SCUSF 0503, NCT00429702
6.	Randomized Study of a Triple Antiemetic Combination Suppository Containing Metoclopramide/Dexamethasone/Diphenhydramine for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Summary Last Modified 07/90) Phase: No phase specified Type: Supportive care Status: Closed Age: 18 to 70 Sponsor: Protocol IDs: UKMC-87GYN03, NCI-V88-0455
7.	Evaluation of MDLO (Metoclopramide/Dexamethasone/Lorazepam/Ondansetron) for the Prevention of Acute Vomiting In Cancer Patients Receiving High-Dose Cisplatin (Summary Last Modified 11/92) Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: Protocol IDs: MSKCC-91072, NCI-V91-0180
8.	Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-13108, NCI-2010-01968, PEP-10-174-1-PCSM, NCT01204255